Vol 61, No 4 (2023)
Original paper
Published online: 2023-12-01

open access

Page views 869
Article views/downloads 537
Get Citation

Connect on Social Media

Connect on Social Media

Periplaneta americana extract attenuates hepatic fibrosis progression by inhibiting collagen synthesis and regulating the TGF-β1/Smad signaling pathway

Yi Chen12, Yanwen Zhao13, Liping Yuan1, Ying He1, Yongshou Yang1, Peiyun Xiao1
Pubmed: 38073317
Folia Histochem Cytobiol 2023;61(4):231-243.

Abstract

Introduction. Liver fibrosis is the damage repair response following chronic liver diseases. Activated hepatic stellate cells (HSCs) are the main extracellular matrix (ECM)-producing cells and key regulators in liver fibrosis. Periplaneta americana shows prominent antifibrotic effects in liver fibrosis; however, the underlying mechanisms remain undetermined. This study aimed to elucidate the therapeutic effects of P. americana extract (PA-B) on liver fibrosis based on the regulation of the TGF-β1/Smad signal pathway.
Material and methods. HSCs and Sprague Dawley rats were treated with TGF-β1 and CCl4, respectively, to establish the hepatic fibrosis model in vitro and in vivo. The effect of PA-B on liver rat fibrosis was evaluated by biochemical (serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), hyaluronic acid (HA), laminin (LN), collagen type IV (Col-IV), pro-collagen type III (PC-III)) and histological examinations. Further, fibrogenic markers expression of alpha smooth muscle actin (α-SMA), collagen type I (Col-I), and collagen type III (Col-III), and the TGF-β1/Smad pathway-related factors were assessed by immunofluorescence (IF), real time quantitative polymerase chain reaction (RT-qPCR), and western blotting (WB).
Results. Treatment of HSC-T6 cells with PA-B suppressed the expression of α-SMA, Col-I, and Col-III, downregulated the expression of TGF-β1 receptors I and II (TβR I and TβR II, respectively), Smad2, and Smad3, and upregulated Smad7 expression. PA-B mitigates pathologic changes in the rat model of liver fibrosis, thus alleviating liver index, and improving liver function and fibrosis indices. The effects of PA-B on the expression of α-SMA, Col-I, Col-III, TβR I, TβR II, Smad2, Smad3, and Smad7 were consistent with the in vitro results, including reduced TGF-β1 expression.
Conclusions. The therapeutic effect of PA-B on liver fibrosis might involve suppression of the secretion and expression of TGF-β1, regulation of the TGF-β1/Smad signaling pathway, and inhibition of collagen production and secretion.

Article available in PDF format

View PDF Download PDF file

References

  1. Shan L, Wang F, Zhai D, et al. New Drugs for Hepatic Fibrosis. Front Pharmacol. 2022; 13: 874408.
  2. Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020; 9(4).
  3. Wang YH, Twu YC, Wang CK, et al. Niemann-Pick type C2 protein regulates free cholesterol accumulation and influences hepatic stellate cell proliferation and mitochondrial respiration function. Int J Mol Sci. 2018; 19(6).
  4. Lu P, Yan M, He Li, et al. Crosstalk between epigenetic modulations in valproic acid deactivated hepatic stellate cells: an integrated protein and miRNA profiling study. Int J Biol Sci. 2019; 15(1): 93–104.
  5. Lo RC, Kim H. Histopathological evaluation of liver fibrosis and cirrhosis regression. Clin Mol Hepatol. 2017; 23(4): 302–307.
  6. Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017; 14(7): 397–411.
  7. Zhangdi HJ, Su SB, Wang F, et al. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World J Gastroenterol. 2019; 25(33): 4835–4849.
  8. Li D, Ma D, Liu Ye, et al. Extracts of Periplaneta americana alleviate hepatic fibrosis by affecting hepatic TGF-β and NF-κB expression in rats with pig serum-induced liver fibrosis. Folia Histochem Cytobiol. 2022; 60(2): 125–135.
  9. Inagaki Y, Okazaki I. Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut. 2007; 56(2): 284–292.
  10. Sun WY, Gu YJ, Li XR, et al. β-arrestin2 deficiency protects against hepatic fibrosis in mice and prevents synthesis of extracellular matrix. Cell Death Dis. 2020; 11(5): 389.
  11. Loboda A, Sobczak M, Jozkowicz A, et al. TGF-β1/Smads and miR-21 in renal fibrosis and inflammation. Mediators Inflamm. 2016; 2016: 8319283.
  12. Chen L, Yang T, Lu DW, et al. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment. Biomed Pharmacother. 2018; 101: 670–681.
  13. Jiang Y, Xiang C, Zhong F, et al. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis. Theranostics. 2021; 11(1): 361–378.
  14. Saito A, Horie M, Nagase T. TGF-β signaling in lung health and disease. Int J Mol Sci. 2018; 19(8).
  15. Hahn O, Ingwersen LC, Soliman A, et al. TGF-ß1 induces changes in the energy metabolism of white adipose tissue-derived human adult mesenchymal stem/stromal cells . Metabolites. 2020; 10(2).
  16. He X, Cheng R, Huang C, et al. A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling. Signal Transduct Target Ther. 2020; 5(1): 45.
  17. Yoshida K, Murata M, Yamaguchi T, et al. TGF-β/Smad signaling during hepatic fibro-carcinogenesis (review). Int J Oncol. 2014; 45(4): 1363–1371.
  18. Cheng Qi, Li C, Yang CF, et al. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways. Chem Biol Interact. 2019; 299: 131–139.
  19. Yang YX, Luo Qi, Hou Bo, et al. Periplanosides A-C: new insect-derived dihydroisocoumarin glucosides from Periplaneta americana stimulating collagen production in human dermal fibroblasts. J Asian Nat Prod Res. 2015; 17(10): 988–995.
  20. Yun J, Hwang JS, Lee DG. The antifungal activity of the peptide, periplanetasin-2, derived from American cockroach . Biochem J. 2017; 474(17): 3027–3043.
  21. Gao Y, Liang LC, Wang R, et al. Chemical constituents from Periplaneta americana. Chin Tradit Patent Med. 2018; 40: 375–378.
  22. Si JG, Zhang T, Li LY, et al. Chemical constituents from Periplaneta Americana. Chin Pharm J. 2018; 53(3): 178–181.
  23. Wang Q, Liu K, Kong C, et al. Current situation on antioxidant stress and active compounds of Periplaneta americana extracts. Chin Arch Tradi Chin Med. 2021; 39: 124–127.
  24. Gao YY, Geng FN, Chen SM, et al. Advances in research on active ingredients and related pharmacology of Periplaneta americana. Chin J Exp Tradit Med Form. 2021; 24: 240–250.
  25. Gu T, Yang YS, Xie JJ, et al. Effects of active extracts from Periplaneta Americana on treating hepatic fibrosis in rats by gastric and intestinal administration. J Dali Univ. 2021; 6: 18–22.
  26. Fu W, Zhao Y, Xie J, et al. Identification of anti-hepatic fibrosis components in Periplaneta americana based on spectrum-effect relationship and chemical component separation. Biomed Chromatogr. 2022; 36(3): e5286.
  27. Naik N, Madani A, Esteva A, et al. Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains. Nat Commun. 2020; 11(1): 5727.
  28. Iezzoni JC. Diagnostic histochemistry in hepatic pathology. Semin Diagn Pathol. 2018; 35(6): 381–389.
  29. Ghasemzadeh N, Pourrajab F, Dehghani Firoozabadi A, et al. Ectopic microRNAs used to preserve human mesenchymal stem cell potency and epigenetics. EXCLI J. 2018; 17: 576–589.
  30. Shi WP, Ju Di, Li H, et al. CD147 promotes CXCL1 expression and modulates liver fibrogenesis. Int J Mol Sci. 2018; 19(4).
  31. Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 2015; 61(3): 1066–1079.
  32. Ezhilarasan D, Sokal E, Najimi M. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets. Hepatobiliary Pancreat Dis Int. 2018; 17(3): 192–197.
  33. Shi W, An Li, Zhang J, et al. extract ameliorates lipopolysaccharide-induced liver injury by improving mitochondrial dysfunction via the AMPK/PGC-1α signaling pathway. Exp Ther Med. 2021; 22(4): 1138.
  34. Yuan L, Yang X, He Y, et al. Mechanism of the anti-liver fibrosis effect of Periplaneta americana extracts that promote apoptosis of HSC-T6 cells through the Bcl-2/Bax signaling pathway. J Asia-Pac Entomol. 2023; 26(2): 102094.
  35. Gasparyan AY, Ayvazyan L, Yessirkepov M, et al. Colchicine as an anti-inflammatory and cardioprotective agent. Expert Opin Drug Metab Toxicol. 2015; 11(11): 1781–1794.
  36. Liu H, Zhang Z, Hu H, et al. Protective effects of Liuweiwuling tablets on carbon tetrachloride-induced hepatic fibrosis in rats. BMC Complement Altern Med. 2018; 18(1): 212.
  37. López-Hernández FJ, López-Novoa JM. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res. 2012; 347(1): 141–154.
  38. Song L, Qu D, Zhang Q, et al. Phytosterol esters attenuate hepatic steatosis in rats with non-alcoholic fatty liver disease rats fed a high-fat diet. Sci Rep. 2017; 7: 41604.
  39. Yanguas SC, Cogliati B, Willebrords J, et al. Experimental models of liver fibrosis. Arch Toxicol. 2016; 90(5): 1025–1048.
  40. Tang G, Seume N, Häger C, et al. Comparing distress of mouse models for liver damage. Sci Rep. 2020; 10(1): 19814.
  41. Manibusan MK, Odin M, Eastmond DA. Postulated carbon tetrachloride mode of action: a review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2007; 25(3): 185–209.
  42. Tabrez S, Ahmad M. Effect of wastewater intake on antioxidant and marker enzymes of tissue damage in rat tissues: implications for the use of biochemical markers. Food Chem Toxicol. 2009; 47(10): 2465–2478.
  43. Liang L, Yang X, Yu Y, et al. Babao Dan attenuates hepatic fibrosis by inhibiting hepatic stellate cells activation and proliferation via TLR4 signaling pathway. Oncotarget. 2016; 7(50): 82554–82566.
  44. Stanko P, Baka T, Repova K, et al. Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension. Front Med (Lausanne). 2020; 7: 325.
  45. Chen X, Li HD, Bu FT, et al. Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis. Theranostics. 2020; 10(11): 4851–4870.
  46. Dawood RM, El-Meguid MA, Salum GM, et al. Key players of hepatic fibrosis. J Interferon Cytokine Res. 2020; 40(10): 472–489.
  47. Yang HY, Kim KS, Lee YH, et al. Ameliorates Thioacetamide-Induced Hepatic Fibrosis via TGF-β1/Smads Pathways. Int J Biol Sci. 2019; 15(4): 800–811.
  48. Zhang L, Liu C, Meng XM, et al. Smad2 protects against TGF-β1/Smad3-mediated collagen synthesis in human hepatic stellate cells during hepatic fibrosis. Mol Cell Biochem. 2015; 400(1-2): 17–28.
  49. Xu F, Liu C, Zhou D, et al. TGF-β/SMAD pathway and its regulation in hepatic fibrosis. J Histochem Cytochem. 2016; 64(3): 157–167.
  50. Sferra R, Vetuschi A, Pompili S, et al. Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis. Pathol Res Pract. 2017; 213(1): 58–65.
  51. Yang N, Dang S, Shi J, et al. Caffeic acid phenethyl ester attenuates liver fibrosis via inhibition of TGF-β1/Smad3 pathway and induction of autophagy pathway. Biochem Biophys Res Commun. 2017; 486(1): 22–28.
  52. Hu HH, Chen DQ, Wang YN, et al. New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018; 292: 76–83.
  53. Ebeid DE, Khalafalla FG, Broughton KM, et al. Pim1 maintains telomere length in mouse cardiomyocytes by inhibiting TGFβ signalling. Cardiovasc Res. 2021; 117(1): 201–211.